What happens when you take lithium with ace inhibitors?
ACE inhibitors lower blood pressure and protect the heart and kidneys, but the same mechanism slows how fast your kidneys clear lithium. The result is a gradual, often delayed rise in serum lithium. Here is the chain of events:
- ACE inhibitors reduce filtration pressure in the kidney. By blocking the formation of angiotensin II, these drugs relax the small artery leaving the glomerulus. This produces a modest, consistent drop in the kidney's filtration rate and reduces aldosterone-driven sodium reabsorption.
- Lithium follows sodium. Lithium is cleared almost entirely by the kidneys without being metabolized, and it is reabsorbed in the same part of the tubule as sodium. When an ACE inhibitor shifts sodium handling and lowers filtration, the kidneys hold on to more lithium.
- Serum lithium climbs. Less lithium leaves the body, so the level in the blood rises. The size of the rise is greater in older adults, in people who are dehydrated, and in those with chronic kidney disease.
- Toxicity can appear late. The most dangerous feature is timing. Levels often do not spike in the first week; published case reports describe lithium toxicity emerging a few weeks after the ACE inhibitor is started, sometimes alongside a drop in kidney function. Someone who tolerated the new blood pressure pill at first can decompensate later.
Why is this important?
Lithium has a narrow therapeutic window, meaning the gap between a helpful level and a harmful one is small. Even a moderate rise can move someone from a steady, effective level toward the range where side effects and toxicity begin. Because the change can build over weeks rather than days, it is easy to miss if no one is watching for it.
The consequences are not trivial. Case reports document patients whose lithium level and kidney markers both rose sharply within weeks of starting an ACE inhibitor, presenting with confusion, tremor, nausea, and impaired kidney function. Lithium toxicity can progress to serious neurological harm if not caught.
Some psychiatric pharmacology references go as far as recommending that ACE inhibitors simply not be combined with lithium when a reasonable alternative exists. In real-world practice the combination is sometimes the right choice — for example in a patient with diabetic kidney disease or heart failure, where an ACE inhibitor offers protection no other class matches — but it is a decision that calls for planned monitoring rather than a wait-and-see approach.
Angiotensin receptor blockers (ARBs) such as losartan and valsartan act through a related mechanism and can raise lithium levels too, so the same caution applies to them.
What should you do?
The guiding principle: this combination is best avoided when an alternative blood pressure drug will do, and closely monitored when it cannot be. Work the plan with your prescriber and pharmacist.
Before any change to your blood pressure medicine:
- Tell every prescriber that you take lithium, so they can weigh alternatives such as a calcium channel blocker before reaching for an ACE inhibitor.
- If an ACE inhibitor is chosen, ask your doctor to check your lithium level and kidney function first, to establish your starting point.
Every day, while on both:
- Stay well hydrated, especially in hot weather or during illness, vomiting, or diarrhea — fluid loss concentrates lithium.
- Avoid adding over-the-counter anti-inflammatory painkillers (NSAIDs like ibuprofen or naproxen) on your own. The combination of an ACE inhibitor, an NSAID, and lithium is particularly risky for the kidneys. Check with a pharmacist first.
- Watch for warning signs of lithium toxicity: new or worsening tremor, nausea, vomiting, diarrhea, confusion, slurred speech, or unsteadiness. Seek medical care promptly if they appear.
After starting the ACE inhibitor or changing a dose:
- Expect repeat lithium and kidney-function checks in the first couple of weeks, and again several weeks out — because toxicity from this interaction often surfaces in that later window.
- Do not stop or change the dose of either drug on your own; review any concerns with your doctor or pharmacist so adjustments are made safely.
Which specific products are affected?
The interaction applies to the ACE inhibitor class as a whole, including lisinopril (Zestril, Prinivil), enalapril (Vasotec), ramipril (Altace), benazepril (Lotensin), captopril (Capoten), perindopril (Aceon), trandolapril (Mavik), fosinopril (Monopril), quinapril (Accupril), and moexipril (Univasc), as well as combination products that pair an ACE inhibitor with hydrochlorothiazide.
ARBs share a similar interaction profile and should be treated with the same caution: losartan (Cozaar), valsartan (Diovan), olmesartan (Benicar), telmisartan (Micardis), candesartan (Atacand), and irbesartan (Avapro).
On the lithium side, the interaction applies to all formulations: lithium carbonate immediate-release (Eskalith, generic) and extended-release (Lithobid), and lithium citrate liquid.
The science behind it
The most-cited evidence is a retrospective case-control study by Finley and colleagues (PMID 8834421), which evaluated patients taking lithium with and without an ACE inhibitor and found that adding an ACE inhibitor meaningfully raised steady-state lithium levels and reduced lithium clearance. This study is the source of the often-quoted estimate of how much lithium rises, and it established the interaction as clinically real rather than theoretical.
A published case report (PMID 32297151) illustrates the delayed, dangerous pattern in practice: a patient developed lithium toxicity with a rising lithium level and worsening kidney function several weeks after an ACE inhibitor was added. As a single-case observation it cannot establish how often this happens, but it reinforces both the mechanism and the importance of late monitoring.
A broader review of lithium drug interactions by Finley (Clinical Pharmacokinetics) places the ACE inhibitor effect alongside other renal interactions, noting that drugs which reduce kidney clearance of lithium predictably raise its serum level, with the largest effects in older and volume-depleted patients.
Frequently Asked Questions
Can I ever take an ACE inhibitor if I'm on lithium?
Yes. The combination is not absolutely forbidden — it is sometimes the best option, particularly for people with diabetic kidney disease or heart failure. What it requires is a deliberate monitoring plan rather than starting and forgetting. Your doctor decides whether the benefit outweighs the need for closer follow-up.
How quickly would a problem show up?
Not necessarily right away, which is what makes this interaction tricky. Lithium levels can rise gradually, and case reports describe toxicity appearing a few weeks after the ACE inhibitor was started. That delayed window is exactly why repeat blood tests weeks later matter.
Are ARBs (like losartan) any safer than ACE inhibitors?
ARBs work through a related pathway and can also raise lithium levels, so they are not a guaranteed safe substitute. If you switch, the same monitoring and caution apply.
What blood pressure medicines are less likely to interact?
Calcium channel blockers are commonly considered when someone on lithium needs blood pressure treatment, because they do not raise lithium levels through this kidney mechanism. Your prescriber will choose based on your full picture, including your heart and kidney health.
Why does dehydration matter so much?
Lithium handling in the kidney tracks closely with sodium and fluid balance. When you are dehydrated — from heat, illness, vomiting, or diarrhea — your kidneys hold on to more lithium, which can magnify the rise an ACE inhibitor already causes. Staying hydrated and reporting illness helps keep levels stable.
What symptoms should make me seek care?
New or worsening tremor, nausea, vomiting, diarrhea, confusion, slurred speech, or unsteadiness can signal lithium toxicity. If these appear after a blood pressure medication change, contact your doctor or seek care promptly.
Key takeaways
- ACE inhibitors slow how fast the kidneys clear lithium, which tends to raise serum lithium levels.
- The rise can be delayed by several weeks, so the interaction is easy to miss without planned follow-up.
- Older adults, dehydrated people, and those with reduced kidney function are most at risk.
- When possible, a different class of blood pressure drug (such as a calcium channel blocker) is preferred for people on lithium.
- When an ACE inhibitor is needed, expect lithium and kidney-function monitoring before starting and over the following weeks.
- Avoid adding NSAID painkillers to this combination on your own, and stay hydrated.
- Learn the signs of lithium toxicity and review the monitoring plan with your doctor or pharmacist.